Gary L. Gottlieb (born May 1955 in Brooklyn, NY), is a prominent psychiatrist, healthcare executive and healthcare investor [1] who served as CEO of Partners in Health from 2015-2019. [2] [3]
In the 1990s and early 2000s, Gottlieb established, chaired, or led various medical centers and departments. [4] [5] From 2010 to 2015, he was president and CEO of Partners HealthCare. [6] He is the only person to appear eight consecutive times in Modern Healthcare magazine's list of the "50 Most Influential Physician Executives in Healthcare." [7]
Gottlieb earned a BS from the Rensselaer Polytechnic Institute, an MD from the Albany Medical College of Union University, and an MBA from the Wharton School of the University of Pennsylvania. He is a professor of psychiatry at Harvard Medical School and a member of the National Academy of Medicine. Gottlieb is also an executive partner of digital health venture capital firm Flare Capital Partners in Boston, MA. [8] He served as a member of the board of directors of the Federal Reserve Bank of Boston from 2012 to 2016 and as its chair from 2016 to 2018. [9] He currently serves on the external advisory board of the University of Pennsylvania's Center for Health Incentives and Behavioral Economics (CHIBE). [10]
He and his wife Derri Shtasel, a psychiatrist, have two children: a son, Corey; and a daughter, Zoe. [11]
Mass General Brigham (MGB) is a not-for-profit, integrated health care system that engages in medical research, teaching, and patient care. It is the largest hospital-based research enterprise in the United States, with annual funding of more than $2 billion. The system's annual revenue was nearly $18 billion in 2022. It is also an educational institution, founded by Brigham and Women's Hospital and Massachusetts General Hospital. The system provides clinical care through two academic hospitals, three specialty hospitals, seven community hospitals, home care services, a health insurance plan, and a robust network of specialty practices, urgent care facilities, and outpatient clinics/surgical centers. It is the largest private employer in Massachusetts. In 2023, the system reported that from 2017–2021 its overall economic impact was $53.4 billion – more than the annual state budget.
David J. Brailer is known for founding and investing in leading health IT companies.
Elizabeth Nabel is an American cardiologist and Executive Vice President of Strategy at ModeX Therapeutics and OPKO Health. Prior to this role, she served as President of Brigham Health and its Brigham and Women's Hospital, Professor of Medicine at Harvard Medical School, and Director of the NIH's National Heart, Lung, and Blood Institute.
The Lahey Hospital & Medical Center, formerly known as the Lahey Clinic, is a physician-led nonprofit teaching hospital of Tufts University School of Medicine based in Burlington, Massachusetts. The hospital was founded in Boston in 1923 by surgeon Frank H. Lahey, M.D., and is managed by Beth Israel Lahey Health. U.S. News & World Report has cited it several times on its list of "America's Best Hospitals" in the category of urology.
Risa J. Lavizzo-Mourey is an American medical doctor and executive who served as president and CEO of the Robert Wood Johnson Foundation from 2003 to 2017. She was the first woman and the first African-American to head the foundation, which has an endowment of about $8 billion and distributes more than $400 million a year. She has been named one of the 100 Most Powerful Women by Forbes several times, and one of The Grio's History Makers in the Making. She was elected a Member of the American Philosophical Society in 2016.
HealthCentral is an American privately owned digital health media company. The company owns and operates consumer health brands HealthCentral.com, TheBody.com, and PatientPower.info, as well as brands for medical professionals including MedCentral.com, TheBodyPro.com, and OncologyNewsCentral.com.
Mitchell J. Blutt is an American physician-businessman. He is one of the first physicians to play a prominent role on Wall Street by drawing on his medical training to identify investment potential in healthcare companies. He is the founder and CEO of the New York-based healthcare investment firm Consonance Capital and a former Executive Partner of J.P. Morgan Partners. He is also a Clinical Assistant Professor of Medicine in the Department of Medicine at Weill Cornell Medicine and the Graduate School of Medical Sciences of Cornell University.
Sachin H. Jain is an American physician who held leadership positions in the Center for Medicare and Medicaid Services (CMS) and the Office of the National Coordinator for Health Information Technology (ONC). From 2015 to 2020, he served as president and chief executive officer of the CareMore Health System. In June 2020, it was announced that he would join the SCAN Group and Health Plan as its new president and CEO. He is also adjunct professor of medicine at the Stanford University School of Medicine and a Contributor at Forbes. In 2018, he was named one of American healthcare's most 100 most influential leaders by Modern Healthcare magazine (#36).
Steward Health Care is a large private for-profit health system headquartered in Dallas, Texas. It utilizes an integrated care model to deliver healthcare across its hospitals and primary care locations, as well as through its managed care and health insurance services. As of the start of 2024, Steward operated 33 hospitals and employed 33,000 people in the United States. Steward's international ventures include Steward Colombia, which operates four hospitals, and Steward Middle East, which operates in Saudi Arabia and the United Arab Emirates. The company is currently engaged in bankruptcy proceedings.
Atrius Health is a Massachusetts based healthcare organization with a system of connected care for adult and pediatric patients in eastern and central Massachusetts. Atrius Health's medical practices work together with the home health and hospice services of its VNA Care subsidiary and in collaboration with hospital partners, community specialists and skilled nursing facilities. Atrius was acquired by Optum on May 31, 2022, which caused it to lose its tax-exempt status, although its charitable assets were transferred to the Atrius Health Equity Foundation.
T. Brian Callister is an American physician who works on care transitions. He is a critic of assisted suicide and euthanasia. Callister was the National Medical Director, Chief Medical Officer and Senior Physician Executive at The LifeCare Family of Hospitals, a system of specialty care hospitals, from 2004 – 2016. He was an academic hospitalist and associate professor of internal medicine in Reno, Nevada. and is the governor-elect of Nevada for the American College of Physicians. Much of his work is focused on healthcare policy, quality improvement, and end-of-life issues.
David Blumenthal is an academic physician and health care policy expert, known as the National Coordinator for Health Information Technology from 2009 to 2011 during the early implementation of the Health Information Technology for Economic and Clinical Health Act provisions on "meaningful use".
Zubin Damania is an American physician, assistant professor, comedian, internet personality, and musician. He also has been writing and performing comedic raps as ZDoggMD, an internet celebrity known for his music videos, parodies, and comedy sketches about medical issues, as well as systemic issues with healthcare.
Jennifer Childs-Roshak is an American physician who is president and CEO of Planned Parenthood League of Massachusetts, president of the Planned Parenthood Advocacy Fund of Massachusetts and a board member of the Boston Public Health Commission. She is the first person with a medical degree to become the chief executive of any Planned Parenthood.
Scott Gottlieb is an American physician, investor, and author who served as the 23rd commissioner of the Food and Drug Administration (FDA) from May 2017 until April 2019. He is presently a senior fellow at the conservative think tank the American Enterprise Institute (AEI), a partner at the venture capital firm New Enterprise Associates (NEA), a member of the board of directors of drug maker Pfizer, Inc and gene sequencing company Illumina, Inc., and a contributor to the cable financial news network CNBC and the CBS News program Face the Nation. An elected member of the National Academy of Medicine, Gottlieb is the author of The New York Times best selling book Uncontrolled Spread on the COVID-19 pandemic and the national security vulnerabilities that it revealed. His forthcoming book, The Miracle Century: Making Sense of the Cell Therapy Revolution, traces the scientific achievements that propelled progress in cell therapies.
Andrew Cohen is an Australian businessman and CEO of leading primary healthcare network ForHealth Group.
Jeffrey Leiden is an American physician, scientist and businessman who is the executive chairman of Vertex Pharmaceuticals, a biotechnology company based in Boston, Massachusetts. He was initially appointed to the board of directors of the company in 2009 and was CEO and president from February 2012 to March 2020.
John Harnett Noseworthy is an American neurologist who served as the president and chief executive officer of Mayo Clinic from 2009 to 2018. A board-certified neurologist specializing in multiple sclerosis, Noseworthy is the former editor-in-chief of Neurology, the official journal of the American Academy of Neurology. Noseworthy has advised the administration of President Donald Trump on health care issues. He has advocated for research funding and telemedicine as a means to reduce the costs of treating patients, among other things. Under Noseworthy's leadership, Mayo Clinic and governments in Minnesota launched the Destination Medical Center (DMC) initiative to advance Minnesota as a global destination for health care and wellness. Prior to his appointment as CEO of Mayo Clinic, Noseworthy held several leadership roles within the organization.
Reshma Kewalramani, is the president and chief executive officer of Vertex Pharmaceuticals, a biotechnology company based in Boston, Massachusetts, as of April 1, 2020. She is the first female CEO of a large US biotech company. She was previously the chief medical officer and vice president of global medicines development and medical affairs at Vertex.
Wael Fahed Al-Husami is a Jordanian cardiologist and interventional cardiologist, scientist and medical educator at Tufts University and a faculty member at Brown University’s Alpert Medical School, and a faculty Member at BIDMC Disaster Medicine Fellowship - Harvard Medical School. Wael Al-Husami is also a visiting professor of Medicine at the Royal College of Surgeons in Ireland.